Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indraprastha MedicalBOM:532150 -1.95%81 Days Payable is 45.99 as of Jun. 2026, which is 15% below its 10-year median of 54.31. GuruFocus rates BOM:532150 with a GF Score™ of 81/100 and a GF Value™ of ₹420.21 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 609 Healthcare Providers & Services companies, Indraprastha Medical ranks worse than 57.96% on this metric.
The historical rank and industry rank for Indraprastha Medical's Days Payable or its related term are showing as below:
BOM:532150'
s Days Payable Range Over the Past 10 Years
Min: 44.32 Med: 54.31 Max: 79.89
Current: 47.97
During the past 13 years, Indraprastha Medical's highest Days Payable was 79.89. The lowest was 44.32. And the median was 54.31.
BOM:532150's Days Payable is ranked worse than 57.96% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs BOM:532150: 47.97
Indraprastha Medical's Days Payable
declined
from Jun. 2025 (49.56) to Jun. 2026 (45.99).
It may suggest that Indraprastha Medicalaccelerated paying its suppliers.
The historical data trend for Indraprastha Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532150 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Indraprastha Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Indraprastha Medical's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indraprastha Medical (BOM:532150) has a Days Payable of 45.99 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indraprastha Medical and its competitors. This is 15% below median its historical median of 54.31. Over the past decade, Indraprastha Medical's Days Payable has ranged from 44.32 to 79.89. According to the industry distribution chart, Indraprastha Medical ranks #353 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 58%.
Is Indraprastha Medical's Days Payable too high?
Indraprastha Medical's current Days Payable of 45.99 is 15% below median its 10-year median of 54.31. Over the past 10 years, this metric has ranged from a low of 44.32 to a high of 79.89. The Healthcare Providers & Services industry median Days Payable is 57.13. Indraprastha Medical's value of 45.99 is 19.5% below this industry median. Based on the distribution chart, Indraprastha Medical ranks #353 out of 609 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Indraprastha Medical has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Indraprastha Medical ranks #353 out of 609 companies for Days Payable. This places Indraprastha Medical in the lower half of its industry. The industry median Days Payable is 57.13. Indraprastha Medical's value of 45.99 is 19.5% below this benchmark. Historically, Indraprastha Medical's own Days Payable has ranged from 44.32 to 79.89 over the past decade. While the company's 10-year median is 54.31 vs. the industry median of 57.13, Indraprastha Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indraprastha Medical's current Days Payable of 45.99 is 19.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Indraprastha Medical and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indraprastha Medical's current Days Payable is 45.99, which is 15% below median its own 10-year median of 54.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.21, compared to a current price of ₹376.95 — trading 10.3% below its estimated fair value. The current Days Payable is 45.99, which is 15% below median its 10-year median of 54.31 and 19.5% below the Healthcare Providers & Services industry median of 57.13. Indraprastha Medical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current Days Payable is 45.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indraprastha Medical (BOM:532150) Overvalued in 2026?
Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued.
The current stock price of ₹376.95 is trading 10.3% below its estimated GF Value™ of ₹420.21.
GuruFocus considers Indraprastha Medical to be Modestly Undervalued.
Key valuation signals for BOM:532150:
Days Payable: 45.99 (15% below median its 10-year median of 54.31)
GF Value™: ₹420.21 vs. price of ₹376.95 (10.3% below fair value)
Industry Position: 19.5% below the Healthcare Providers & Services median (#353 of 609)
No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
81GF Score
Get the complete analysis for BOM:532150
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532150 has been successfully added to your 
